Alkermes
Alkermes is a biopharmaceutical company that develops medicines for psychiatric and neurological disorders, operates GMP manufacturing facilities in the U.S. and Ireland, and actively supports mental health initiatives and patient advocacy.
Services
Alkermes provides a variety of services within the biomedical and pharmaceuticals sectors. The company is known for developing innovative medicines in neuroscience intended to tackle complex and challenging psychiatric and neurological disorders. Engaging in patient advocacy, Alkermes endeavors to enhance patient-centered drug development and improve access to medications. They also conduct clinical trials to verify the safety and effectiveness of their experimental medicines, and offer early access to investigational therapies under specified conditions.
Products
Alkermes has a diverse portfolio of proprietary commercial products aimed at treating alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder. Utilizing proprietary technologies such as Medisorb®, LinkeRx®, and NanoCrystal®, Alkermes develops medications with unique therapeutic properties designed to meet unmet medical needs. By leveraging these advanced technologies, the company seeks to create effective treatments for a variety of serious diseases.
Manufacturing Facilities
Alkermes operates GMP (Good Manufacturing Practice) manufacturing facilities located in Wilmington, Ohio, and Athlone, Ireland. These facilities are instrumental in producing the company's broad array of pharmaceutical products, ensuring compliance with stringent quality standards to provide safe and effective medicines.
Awards and Recognitions
Alkermes has garnered several notable recognitions for its contributions to workplace mental health and family-oriented workplace practices. In 2023, the company was awarded the Platinum Bell Seal for Workplace Mental Health by Mental Health America, acknowledging its efforts to foster a mentally healthy work environment. Additionally, in 2024, Alkermes was named a Best Place for Working Parents among Massachusetts businesses, highlighting its commitment to supporting working parents within its corporate framework.
Community Engagement
Alkermes is actively involved in community engagement through programs like the Alkermes Inspiration Grants. This initiative has granted over $5 million to support innovative programs aimed at addressing the needs of individuals impacted by serious diseases. Through such initiatives, Alkermes demonstrates its dedication to contributing positively to the broader community and promoting public health.